From screening to lifestyle intervention: real-world results of HALT2Diabetes in high-risk adults
Abstract
Background: Cardiometabolic diseases (CMD) are major public health challenges driven by modifiable lifestyle factors. Early identification and intervention for high-risk individuals (HRI) is essential. HALT2Diabetes is a Flemish prevention program using a stepwise approach: Web-based risk assessment (FINDRISC) followed by general practitioner (GP) consultation and referral to group-based lifestyle education. This study, situated within JACARDI, evaluates its real-world effectiveness and implementation outcomes.
Methods: A longitudinal repeated-measures study was conducted in 9 primary care regions across Flanders. HRI participated in 6 group-based lifestyle sessions led by dietitians. Data were collected at 5 time points over 12 months. Outcomes included behavioral, anthropometric, and biochemical measures. Linear mixed models assessed changes over time, including all available observations from the first 3 time points.
Results: Across Flanders, 3,756 individuals completed web-based risk assessment, identifying 1,490 HRI; 344 HRI participated in group-based lifestyle sessions. In 9 primary care regions implementing the study protocol, 87 participants were enrolled at baseline; 71 completed the intervention (82% retention). Significant improvements were observed, including an increase in dietary score (+4.6 points; p < 0.001), reductions in body weight (−1.5 kg; p < 0.001), waist circumference (−1.4 cm; p = 0.001), systolic blood pressure (−7.2 mmHg; p < 0.001), total cholesterol (−6.2 mg/dL; p = 0.047), and LDL cholesterol (−6.4 mg/dL; p = 0.002). Physical activity, diastolic blood pressure, HDL cholesterol, and HbA1c showed no significant change.
Conclusions: HALT2Diabetes improves cardiometabolic risk factors in a real-world setting for participants, but the intervention’s reach is low. Improving referral & retention could increase population level impact. Scaling across EU Member States may strengthen evidence and reduce burden of CMD, in line with the EU Safe Hearts Plan.
Key messages: • Group-based lifestyle education shows the potential to reduce cardiometabolic risk in high-risk populations but reach of current design is low.
• Optimising reach is necessary to increase population health impact. Scaling this model can strengthen EU prevention systems and reduce the burden of CVD and T2D.
Related
- mHealth-based lifestyle intervention for hypertension in community-dwelling adults: a cluster-randomized controlled trial with exploratory multi-omics analyses
- Effect of a Phenotype-Tailored Lifestyle Intervention on Caloric Intake and Macronutrient Composition in Adults with Obesity: A Secondary Analysis of the PHENO-Diet Trial
- Promoting Community Living and Participation Outcomes Among Young Autistic Adults: Promising Results for an Autistic-Delivered Peer Support Intervention
- Impact of a lifestyle intervention for weight loss on liver-related outcomes in adults with obesity: a subanalysis of a clinical trial
- Effectiveness of a mHealth nutrition and lifestyle intervention (mHENAL) in reducing Cardiovascular Disease Risk in Sri Lankan adults: A Randomized Control Trial
BibTeX
@article{leysen2026from,
title = {{From screening to lifestyle intervention: real-world results of HALT2Diabetes in high-risk adults}},
author = {W Leysen and J Van Olmen and J Vergauwen and F Monnet},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.609},
url = {https://doi.org/10.1093/eurpub/ckag169.609},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - From screening to lifestyle intervention: real-world results of HALT2Diabetes in high-risk adults
AU - W Leysen
AU - J Van Olmen
AU - J Vergauwen
AU - F Monnet
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.609
UR - https://doi.org/10.1093/eurpub/ckag169.609
AB - Background: Cardiometabolic diseases (CMD) are major public health challenges driven by modifiable lifestyle factors. Early identification and intervention for high-risk individuals (HRI) is essential. HALT2Diabetes is a Flemish prevention program using a stepwise approach: Web-based risk assessment (FINDRISC) followed by general practitioner (GP) consultation and referral to group-based lifestyle education. This study, situated within JACARDI, evaluates its real-world effectiveness and implementation outcomes. Methods: A longitudinal repeated-measures study was conducted in 9 primary care regions across Flanders. HRI participated in 6 group-based lifestyle sessions led by dietitians. Data were collected at 5 time points over 12 months. Outcomes included behavioral, anthropometric, and biochemical measures. Linear mixed models assessed changes over time, including all available observations from the first 3 time points. Results: Across Flanders, 3,756 individuals completed web-based risk assessment, identifying 1,490 HRI; 344 HRI participated in group-based lifestyle sessions. In 9 primary care regions implementing the study protocol, 87 participants were enrolled at baseline; 71 completed the intervention (82% retention). Significant improvements were observed, including an increase in dietary score (+4.6 points; p < 0.001), reductions in body weight (−1.5 kg; p < 0.001), waist circumference (−1.4 cm; p = 0.001), systolic blood pressure (−7.2 mmHg; p < 0.001), total cholesterol (−6.2 mg/dL; p = 0.047), and LDL cholesterol (−6.4 mg/dL; p = 0.002). Physical activity, diastolic blood pressure, HDL cholesterol, and HbA1c showed no significant change. Conclusions: HALT2Diabetes improves cardiometabolic risk factors in a real-world setting for participants, but the intervention’s reach is low. Improving referral & retention could increase population level impact. Scaling across EU Member States may strengthen evidence and reduce burden of CMD, in line with the EU Safe Hearts Plan. Key messages: • Group-based lifestyle education shows the potential to reduce cardiometabolic risk in high-risk populations but reach of current design is low. • Optimising reach is necessary to increase population health impact. Scaling this model can strengthen EU prevention systems and reduce the burden of CVD and T2D.
SN - 1101-1262
SN - 1464-360X
ER -